Hidradenitis Suppurativa: Causes, Symptoms, Diagnosis and Treatment: By Shreoshree Chakrabarty Hidradenitis Suppurativa (HS) is a long-term skin condition marked by painful, swollen lumps that often ...
Yahoo: Everything You Need to Know About Hidradenitis Suppurativa—From Symptoms to Treatment
The American Journal of Managed Care: Building Hidradenitis Suppurativa Treatment Plan: Evaluating Standard of Care Pharmacotherapies
Panelists discuss the importance of coordinated, personalized treatment strategies for hidradenitis suppurativa, highlighting early use of pharmacologic therapies—including biologics—and ongoing ...
Treatment for hidradenitis suppurativa (HS) varies depending on the condition’s severity. Early HS can be manageable with medication, while more severe cases may require both medication and surgery.
The American Journal of Managed Care: Approved Hidradenitis Suppurativa Treatments and Pipeline Show Similar Efficacy, Safety Without Head-to-Head Trials
Hidradenitis suppurativa patients report dissatisfaction with treatment options and face long diagnostic delays, highlighting significant unmet needs. Adalimumab, secukinumab, and bimekizumab are key ...
Approved Hidradenitis Suppurativa Treatments and Pipeline Show Similar Efficacy, Safety Without Head-to-Head Trials
Hidradenitis suppurativa (HS) is a chronic skin condition that causes swollen and painful lesions beneath the skin. There is currently no cure for hidradenitis suppurativa and treatment focuses on ...
Hidradenitis suppurativa (also known as acne inversa) is a chronic, noncontagious, inflammatory condition characterized by pimple-like bumps or boils and tunnels or tracts on and under the skin.
Hidradenitis Suppurativa (HS) Hidradenitis suppurativa (also known as acne inversa) is a chronic, noncontagious, inflammatory condition characterized by pimple-like bumps or boils and tunnels or tracts on and under the skin.
The possible underlying role of NETs in the pathogenesis of autoinflammatory or autoimmune conditions such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and hidradenitis suppurativa (HS) is a major research focus. Specifically, Dr. Carmona-Rivera studies how NETs promote adaptive immune dysregulation and organ damage.